215. Tetralogy of Fallot Clinical trials / Disease details
Clinical trials : 18 / Drugs : 26 - (DrugBank : 14) / Drug target genes : 13 - Drug target pathways : 45
Showing 1 to 10 of 18 diseases
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT05579964 (ClinicalTrials.gov) | October 10, 2022 | 11/10/2022 | The Role of Dexmedetomidine as Myocardial Protector in Pediatric Cardiac Surgery Total Correction of Tetralogy of Fallot The Role of Dexmedetomidine as Myocardial Protector in Pediatric Cardiac Surgery Total Correction of ... | The Role of Dexmedetomidine as Myocardial Protector in Pediatric Cardiac Surgery Total Correction of Tetralogy of Fallot The Role of Dexmedetomidine as Myocardial Protector in Pediatric Cardiac Surgery Total Correction of ... | Congenital Heart Disease in Children;Cardiopulmonary Bypass;Tetralogy of Fallot | Drug: Dexmedetomidine Hcl 100 Mcg/mL Inj;Drug: Placebo | National Cardiovascular Center Harapan Kita Hospital Indonesia | NULL | Recruiting | 1 Month | 18 Years | All | 66 | Phase 2/Phase 3 | Indonesia |
2 | NCT05186415 (ClinicalTrials.gov) | August 23, 2022 | 20/12/2021 | Contrast Enhanced Three Dimensional Echocardiographic Quantification of Right Ventricular Volumes in Repaired Congenital Heart Disease Contrast Enhanced Three Dimensional Echocardiographic Quantification of Right Ventricular Volumes in ... | Contrast Enhanced Three Dimensional Echocardiographic Quantification of Right Ventricular Volumes in Repaired Congenital Heart Disease Contrast Enhanced Three Dimensional Echocardiographic Quantification of Right Ventricular Volumes in ... | Tetralogy of Fallot;Pulmonary Insufficiency | Drug: Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON] | Nemours Children's Health System | Thomas Jefferson University | Recruiting | 11 Years | N/A | All | 60 | Phase 1/Phase 2 | United States |
3 | NCT05176782 (ClinicalTrials.gov) | December 15, 2021 | 15/12/2021 | Comparison Between Histidine-tryptophan-ketoglutarate Cardioplegia and Cold Blood Cardioplegia for Myocardial Protection for Fallot Tetralogy Patients Undergoing Total Repair Comparison Between Histidine-tryptophan-ketoglutarate Cardioplegia and Cold Blood Cardioplegia for M ... | Randomized Clinical Trial: Comparison Between Histidine-tryptophan-ketoglutarate Cardioplegia and Cold Blood Cardioplegia for Myocardial Protection for Fallot Tetralogy Patients Undergoing Total Repair Randomized Clinical Trial: Comparison Between Histidine-tryptophan-ketoglutarate Cardioplegia and Co ... | Anesthesia | Drug: HTK cardioplegia;Drug: Cold Cadioplegia | Ain Shams University | NULL | Recruiting | 6 Months | 5 Years | All | 52 | Early Phase 1 | Egypt |
4 | ChiCTR2000033234 | 2020-06-05 | 2020-05-25 | Comprehensive study for surgical effect and prognosis of Tetralogy of Fallot | A single-center ambispective cohort study for surgical effect and prognostic factors of Tetralogy of Fallot after surgical repair A single-center ambispective cohort study for surgical effect and prognostic factors of Tetralogy of ... | Tetralogy of Fallot | TOF AS:annlus-sparing repair;TOF TAPE:transannular patch enlargement; | Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and ... | NULL | Pending | Both | TOF AS:247;TOF TAPE:247; | N/A | China | ||
5 | NCT04017975 (ClinicalTrials.gov) | December 20, 2019 | 10/7/2019 | Optical Tissue Identification for Myocardial Architecture | Optical Tissue Identification for Myocardial Architecture (OPTIMA Study) | Ventricular Septal Defect;Complete Atrioventricular Canal;Tetralogy of Fallot With Pulmonary Stenosis Ventricular Septal Defect;Complete Atrioventricular Canal;Tetralogy of FallotWith Pulmonary Stenosis ... | Drug: Fluorescite;Device: Cellvizio 100 Series System with Confocal Miniprobes | Aditya Kaza | National Heart, Lung, and Blood Institute (NHLBI) | Active, not recruiting | 30 Days | 18 Years | All | 70 | Phase 2 | United States |
6 | ChiCTR1900025513 | 2019-09-01 | 2019-08-31 | The safety and efficacy of preoperative oral supplementation of coenzyme Q10 in improving postoperative cardiac function in children with tetralogy of fallot (pulmonary atresia): a preliminary study The safety and efficacy of preoperative oral supplementation of coenzyme Q10 in improving postoperat ... | The safety and efficacy of preoperative oral supplementation of coenzyme Q10 in improving postoperative cardiac function in children with tetralogy of fallot (pulmonary atresia): a preliminary study The safety and efficacy of preoperative oral supplementation of coenzyme Q10 in improving postoperat ... | tetralogy of fallot (pulmonary atresia) | 01:N/A ;02:Oral coenzyme Q10, 2.5mg, t.i.d.;03:Oral coenzyme Q10, 5mg, t.i.d.;04:Oral coenzyme Q10, 10mg, t.i.d.;05:Oral coenzyme Q10, 20mg, t.i.d.; 01:N/A ;02:Oral coenzyme Q10, 2.5mg, t.i.d.;03:Oral coenzyme Q10, 5mg, t.i.d.;04:Oral coenzyme Q10, ... | Fuwai Central China Cardiovascualr Hospital | NULL | Pending | 0 | 2 | Both | 01:8;02:8;03:8;04:8;05:8; | China | |
7 | ChiCTR1800019578 | 2018-12-01 | 2018-11-18 | Effects of different tranexamic acid regimen in cyanotic pediatric cardiac surgery | Effects of different tranexamic acid regimen in cyanotic pediatric cardiac surgery | Tetralogy of Fallot | Conventional treatment group:Childen did not receive an antifibrinolytic agent during surgery;Low dose of tranexamic acid group:Loading dose: 10mg/kg (infant), 5mg/kg (children); Infusion: 2mg/kg.h; CPB prime dose: 20ug/mL of prime volume;High dose of tranexamic acid group:Loading dose: 30mg/kg (infant), 15mg/kg (children); Infusion: 6mg/kg.h; CPB prime dose: 60ug/mL of prime volume; Conventional treatment group:Childen did not receive an antifibrinolytic agent during surgery;Low do ... | National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and ... | NULL | Pending | Both | Conventional treatment group:225;Low dose of tranexamic acid group:225;High dose of tranexamic acid group:225; | China | |||
8 | ChiCTR-IOR-16008571 | 2016-06-06 | 2016-05-31 | Premedication for children with Tetralogy of Fallot | A comparative evalution of varies premedication regimes on children with Tetralogy of Fallot | Tetralogy of Fallot | oral dexmedetomidine:oral dexmedetomidine;oral ketamine:oral ketamine;oral dexmedetomidine mixed with ketamine:oral dexmedetomidine mixed with ketamine; oral dexmedetomidine:oral dexmedetomidine;oral ketamine:oral ketamine;oral dexmedetomidinemixed with ... | Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University | NULL | Recruiting | Both | oral dexmedetomidine:20;oral ketamine:20;oral dexmedetomidine mixed with ketamine:20; | China | |||
9 | EUCTR2013-002091-41-NL (EUCTR) | 09/10/2014 | 05/11/2013 | Research into the effect of the drug losartan in adult patients with a reduced function of the right cardiac chamber and a cardiac birth defect Research into the effect of the drug losartan in adult patients with a reduced function of the right ... | Right vEntricular Dysfunction in tEtralogy of Fallot: INhibition of the rEnin-angiotensin-aldosterone system - Redefine trial Right vEntricular Dysfunction in tEtralogy of Fallot: INhibition of the rEnin-angiotensin-aldosteron ... | To study the effect of losartan in adult patients with Tetralogy of Fallot and right ventricular dysfunction, defined as right ventricular ejection fraction <50%. Without severe valvular lesions.;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14] To study the effect of losartan in adult patients with Tetralogy of Fallotand right ventricular dysf ... | Trade Name: Losartan Product Name: Losartan INN or Proposed INN: Losartan Potassium Other descriptive name: LOSARTAN POTASSIUM Trade Name: Losartan Product Name: Losartan INN or Proposed INN: LosartanPotassium Other descriptive na ... | Academisch medisch centrum | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | Netherlands | ||||
10 | NCT01915277 (ClinicalTrials.gov) | April 2, 2014 | 30/7/2013 | A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety a ... | A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety a ... | Transposition of the Great Arteries;Tetralogy of Fallot;Ventricular Septal Defect | Drug: Dexmedetomidine | HealthCore-NERI | National Heart, Lung, and Blood Institute (NHLBI) | Completed | N/A | 180 Days | All | 119 | Phase 1 | United States |